Elizabeth Trehu

Chief Medical Officer, Jounce Therapeutics.

Companies

Jounce TherapeuticsChief Medical Officer Jan 26, 2017 to Jan 11, 2023¹
Constellation Pharmaceuticals (United States)Board member Sep 5, 2018 to Jul 19, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Jounce Therapeutics JNCE103,417 shares³Jan 10, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 10, 2023Sold 5,126 shares at $1.12 of Jounce Therapeutics³
Jan 9, 2023Sold 4,159 shares at $1.10 of Jounce Therapeutics³
Feb 1, 2022Granted 27,500 shares of Jounce Therapeutics⁴
Jan 10, 2022Sold 5,378 shares at $6.65 of Jounce Therapeutics⁵
Jan 7, 2022Sold 3,005 shares at $7.30 of Jounce Therapeutics⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARJounce Therapeutics, Chief Medical Officer
2
SEC EDGARConstellation Pharmaceuticals (United States), Board member
3
SEC EDGARJounce Therapeutics shares after the filing of Jan 10, 2023
4
SEC EDGARForm 4 filed Feb 3, 2022
5
SEC EDGARForm 4 filed Jan 11, 2022